key: cord-1043197-9nmbh23o
authors: Osama El-Gendy, Ahmed; Saeed, Haitham; Ali, Ahmed M.A.; Zawbaa, Hossam M.; Gomaa, Dina; Harb, Hadeer S.; Madney, Yasmin M.; Osama, Hasnaa; Abdelrahman, Mona A.; Abdelrahim, Mohamed E.A.
title: Bacillus Calmette–Guérin vaccine, age and gender relation to COVID-19 spread and mortality
date: 2020-07-03
journal: Vaccine
DOI: 10.1016/j.vaccine.2020.06.083
sha: 5f6aedb3a4462c340af50429263f4597b1de9b8f
doc_id: 1043197
cord_uid: 9nmbh23o

Abstract COVID-19 is affecting different countries all over the world with great variation in infection rate and death ratio. Some reports suggested a relation between the Bacillus Calmette-Guérin (BCG) vaccine and the malaria treatment to the prevention of SARS-CoV-2 infection. Some reports related infant's lower susceptibility to the BCG vaccine. Some other reports a higher risk in males compared to females in such COVID-19 pandemic. Also, some other reports claimed the possible use of chloroquine and hydroxychloroquine as prophylactic in such a pandemic. The present commentary is to discuss the possible relation between those factors and SARS-CoV-2 infection.

COVID-19 affected around 5,000,000 around the world with a different percentage of mortality with overall mortality rate of about 6.6 % [1]. COVID-19 disease is related to the respiratory infectious diseases caused by coronavirus, the recent attacks of coronavirus were in 2003 caused the severe acute respiratory syndrome (SARS) followed by the Middle east respiratory syndrome (MERS) in 2012 [2, 3] . Animals are the source for coronaviruses, the Camel for MERS and Civet for SARS, the virus is transferred to these animals from bats [3, 4] .

The COVID-19 is transmitted during close contact with infected subject via droplets and fomites.

Till now the airborne spread of new coronavirus has not been proven and so this route of transmission is not believed to be the main driver of virus transmission, but also it is possible for the new virus to be transmitted through airborne in specific conditions (e.g. aerosol generating procedures) [5, 6] .

Another route which is suspected to play a role in transmission of the infection is the fecal-oral route [7] . This possibility was supported by the results of stool samples analysis through PCR for 8 subjects that were confirmed to be infected with the new coronavirus [7] . Also, another study showed that the genome of the new coronavirus was also detected in the esophagus, stomach, and intestine and this support the possibility of the gastrointestinal route transmission [8] .

The majority of subjects have a mild presentation to the infection and mainly start with fever and dry cough that recovers without any interventions; also the flu-like symptoms, malaise, headache, and muscle pain might develop early [9] . Younger subjects represent the majority of mild cases [10] . These mild symptoms might develop to more severe presentation presented as shortness of the breath, that mainly occurs after one week from initial presentation [11] , and pneumonia which require hospitalization of the infected subjects. The severity of the infection might progress to develop respiratory failure, multi-organ failure or septic shock [11] .

The infection started in China in which more than 80,000 confirmed cases were diagnosed with the new coronavirus, the death rate in China is around 4%, while it is greater than 10% in Italy.

SARS-CoV-2 transferred from China to most countries around the world. The spread of the disease became higher in Europe and the USA compared to China (Table 1 ). The number of confirmed SARS-CoV-2 cases detected in countries neighbouring China e.g. Kazakhstan, India, and Korea was lower than that detected in The USA and Europe e.g. Italy, Spain, France, and the UK. To the extent that a close contact area to COVID-19 source, Hong Kong, has around 1000 confirmedcases with very low mortality-rate of 0.71%. The USA now became the highest country with confirmed COVID-19 cases and progressing. One confusing debate raised right now is the possible relation between the vaccination schedule in different countries and its possible relation to the prevention of the spread of SARS-CoV-2 infection. Also, during the current COVID-19 outbreak, it was reported that infants are less susceptible to such a violent virus [12, 13] . One of the proposed explanations is the presence of cross reaction between SARS-CoV-2 and any of childhood vaccines [14] . One of the vaccines that were related to COVID-19 is the Bacillus Calmette-Guérin (BCG) which originates from an attenuated strain of Mycobacterium Bovis for prevention of Mycobacterium tuberculosis infection that causes disseminated and meningeal tuberculosis [15] .

Many countries stopped using BCG vaccine except for high risk vulnerable groups [16] e.g. Italy, the USA, the UK, Spain, and France. Other countries are still using BCG vaccine till now e.g.

African and Asian countries as shown in Figure 1A (Table 1 and Figure 1B ). This possibility could be due to the expected preventive immunization role of the BCG vaccine on the lungs and other organs. What is noticeably parallel between Mycobacterium tuberculosis (TB) and SARS-CoV-2 is that both of them attack primarily the lungs and interfere with host immunity.

Besides the main role of the BCG vaccine in the prevention of TB but there is also a sequence of non-specific effects that could be harboured [18] . Such non-specific effects are termed heterologous effects which are commonly accompanied by live attenuated vaccines e.g., BCG, measles vaccine, oral polio vaccine, smallpox vaccine) that have been shown to non-specifically lessen mortality in addition to prevention of the targeted infections especially in low income countries following immunization programs [19] It was reported that live attenuated measlesmumps-rubella vaccine (MMR) could protect against nosocomial infectious diseases and respiratory syncytial virus [20] Heterologous effects of BCG accordingly can protect against non-mycobacterial infections to generally lower respiratory tract infections in children through activation of innate immunity memory based myeloid cells, a process termed trained immunity [21] [22] [23] . BCG vaccination is associated with a 30% reduction in mortality rate by pathogens especially in developing countries[24] and 50% reduction in mortality related to pneumonia [25] .

The favourable non-specific effects of the BCG vaccine persist for a time after the neonatal period up to 10 years [26]. Trained immunity is referred to innate immune system that could display memory characteristics, after spiked by pathogens or certain live attenuated vaccines ("training effect"), not only toward the same infectious agents but also non-specifically against different pathogens (cross-protection). Trained immunity cannot be defined as sole innate as it is induced only secondary to primary infection. Meanwhile, it is different than adaptive because it shows nonspecific response compared to T/B cell responses [27] . The overall values of trained immunity is attributed to long-term sensitivity of innate immune cells to any microbial stimuli, increasing the response to the same and different subsequent stimuli, and consequently increased cytokine production (not only against TB but also against bacteria, viruses, and even parasites) mediated by and hence the beneficial effects of BCG is more evident in females [39] . This is remarkable by looking into the percentage of deaths to COVID-19 that was higher in males rather than females.

Cytotoxic T-lymphocytes could also be driven by IL-2, IL-12, TNF, and IFN-γ. IFN-γ is secreted by T-cells and Natural-killer (NK) cells and has many roles as antiviral activity, strong regulatory of the-immune response, stimulation of phagocytic bactericidal activity, induction of antigen presentation through major histocompatibility-complex (MHC) molecules, arrangement of leukocyte-endothelium interactions and effects on cell proliferation and apoptosis [40] . IL-8 is For such non-specific mechanisms and evidences, we assume that BCG can be used as an immune modulator to protect against COVID-19 by allocating pulmonary cells under continuous stress which is unfavourable for multiplication of SARS-CoV-2 inside. This strategy will be very helpful in epidemic-control, preventing the spread of infection, limiting the course of the disease and reducing morbidity and mortality rate. This is not the first time to recommend BCG to nonspecifically protect or even treat many pathogens other than TB and diseases especially pulmonary diseases. BCG has shown a protective effect against leprosy which is likely due to cross reactivity with mycobacterial antigens [41] . Other studies reinforced the nonspecific effects against leishmania and malaria decreasing their risks and neonatal mortality [42, 43] . Some experimental studies showed that BCG can protect against viral pathogens [42] . BCG was considered as a supplementary treatment for non-muscle-invasive bladder cancer by triggering the body's immune system to release cytokines and activating cytotoxic cells to destroy tumour cells after/with transurethral resection of bladder tumour (TURBT) cytotoxic cells [44, 45] . Also, it has a protective effect against other cancers showing an inhibitory effect on tumour growth and was reported to reduce the risk of leukemia and lung cancer [46, 47] . BCG has been reported to prevent lung injury by improving the alveolar surface area which is attributed to the preserved IL-13 expression and up-regulation of Nuclear Factor Kappa-B Subunit-1 (NFkB1), Fibroblast growth factor binding protein-1 (FGF.BP1) and Vascular endothelial growth factor A (VEGF-A) genes [48] . Researchers noticed a decreased rate of allergic asthma in children immunized with the BCG vaccine with the general improvement of lung function through increasing the secretion of T-helper type-1 (Th1) cytokines [49, 50] .

Our advice to reallocate BCG for protection against COVID-19 is built on the capability of the BCG vaccine to induce increased cytokine production which will decrease the infectivity of SARS- Another assumption is based on the continuous cytokine production in pulmonary cells after vaccination with BCG [52] will promote pulmonary cells to be more trained and adapted to cytokines for a long time and will be less responsive to side effects of cytokine storm induced by COVID-19 knowing that the cytokine storm is the main cause of respiratory failure and death of COVID-19. [53, 54] The cytokine storm of COVID-19 is a lethal immune condition characterized by activation and proliferation of macrophages, NK cells, T cytotoxic cells and the overproduction of inflammatory cytokines and mediators. The uncontrolled release of pro-inflammatory mediators, IL-6, IL-8, IL-1β, and GM-CSF in addition to reactive oxygen species (ROS) could cause acute respiratory distress syndrome (ARDS) leading to pulmonary fibrosis and death [53] .

April 2020, to address such role of BCG vaccination in protection against COVID-19 especially for healthcare workers and WHO will evaluate the evidence when it is available [55] [56] [57] .

On the other hand, in African countries, the number of confirmed cases is considered very low compared to Europe or even China. The highest country with confirmed cases is Egypt with around 10000 confirmed cases. Malaria disease is considered as a common disease in those countries, as shown in Figure 1C [58] . They mostly receive malaria treatment e.g. Angola, Benin, and Ethiopia, with their very low number of confirmed cases and death with low mortality rates ( Figure 1D ). This finding in countries encountered malaria could be related to the malaria treatment e.g.

chloroquine, which has around 50 days half-life [59] , and hydroxychloroquine, which have around 40 days half-life [59] , that were proven effective against SARS-CoV-2 virus [60] . This long biological half-life could be the reason for such a low number of confirmed cases and worth further investigation. Hydroxychloroquine lowers the pH which can interfere with the replication of the virus through inhibition of lysosomal activity in antigen presenting cells involving B-cells and the plasmacytoid dendritic cells. This will prevent processing of the antigen [61] . In addition to the role of chloroquine and hydroxychloroquine in immunity modulation, also they have an inhibitory effect on two essential steps needed by the new coronavirus to enter the cells, these steps are binding to receptor (angiotensin-converting enzyme 2 (ACE2)) and fusion to cell membrane through the interfering with the glycosylation of the receptor [62, 63] . Again, while the full details are not known, the chloroquine and hydroxychloroquine could be recommended for the preventio of SARS-CoV-2 infection. [63] Hydroxychloroquine, also, is likely to attenuate the severe progression of COVID-19, inhibiting the cytokine storm by suppressing T-cell activation. It has a safer clinical profile and is suitable for those who are pregnant and inexpensive and more readily available. [63] However, the side effect of the chloroquine and hydroxychloroquine and any possible interaction should be taken into account [64, 65] . 

SARS: systematic review of treatment effects

Evidence for camel-to-human transmission of MERS coronavirus

Bats, civets and the emergence of SARS, in Wildlife and emerging zoonotic diseases: the biology, circumstances and consequences of crossspecies transmission

Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations: scientific brief

Airborne transmission of SARS-CoV-2: The world should face the reality

Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding

Evidence for gastrointestinal infection of SARS-CoV

Clinical progression of patients with COVID-19 in

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet

Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series

Novel coronavirus-important information for clinicians

Vaccination in the prevention of infectious respiratory diseases in adults

The ongoing story of the Bacille Calmette-Guérin (BCG) vaccination

The BCG World Atlas: a database of global BCG vaccination policies and practices

Making sense of emerging evidence on the non-specific effects of the BCG vaccine on malaria risk and neonatal mortality

Nonspecific effects of vaccines and the reduction of mortality in children

Measles-mumps-rubella vaccination and respiratory syncytial virusassociated hospital contact

Acute lower respiratory infection among Bacille Calmette-Guérin (BCG)-vaccinated children

Cellular responses to interferon-γ. Annual review of immunology

BCG vaccination reduces risk of infection with Mycobacterium tuberculosis as detected by gamma interferon release assay. Vaccine

Non-specific effects of BCG vaccine on viral infections

BCG vaccination is associated with reduced malaria prevalence in children under the age of 5 years in sub-Saharan Africa

Use of bacille Calmette-Guérin in superficial bladder cancer. Postgraduate medical journal

Canadian guidelines for treatment of non-muscle invasive bladder cancer: a focus on intravesical therapy

Early vaccination protects against childhood leukemia: a systematic review and meta-analysis. Scientific reports

Association of BCG Vaccination in Childhood With Subsequent Cancer Diagnoses: A 60-Year Follow-up of a Clinical Trial

BCG lowers plasma cholesterol levels and delays atherosclerotic lesion progression in mice

The inverse association between tuberculin responses and atopic disorder

Therapeutic effects of BCG vaccination in adult asthmatic patients: a randomized, controlled trial

Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study

Systemic BCG immunization induces persistent lung mucosal multifunctional CD4 TEM cells which expand following virulent mycobacterial challenge

Cytokine storm intervention in the early stages of COVID-19 pneumonia

COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet

BCG Vaccine for Health Care Workers as Defense Against COVID 19 (BADAS)

BCG Vaccination to Protect Healthcare Workers Against COVID-19 (BRACE)

Reducing Health Care Workers Absenteeism in Covid-19

Pandemic Through BCG Vaccine (BCG-CORONA)

Social implications of malaria and their relationships with poverty. Mediterranean journal of hematology and infectious diseases

Bioavailability of hydroxychloroquine tablets in healthy volunteers

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

Intracellular transport of class II MHC molecules directed by invariant chain

Chloroquine is a potent inhibitor of SARS coronavirus infection and spread

COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression

Chloroquine blocks a mutant Kir2. 1 channel responsible for short QT syndrome and normalizes repolarization properties in silico

Chloroquine cardiotoxicity mimicking connective tissue disease heart involvement

COVID-19 is affecting different countries all-over the-world with great variation in infection-rate and death-ratio

Some reports suggested a-relation between the-Bacillus Calmette-Guérin (BCG) vaccine and themalaria-treatment to the-infection prevention

Some reports related-infant's lower-susceptibility to the-BCG-vaccine. Some other reports a higher-risk in males compared to females in such a COVI-19-pandemic

Some other reports claimed the-possible-use of chloroquine and hydroxychloroquine as prophylactic in such a pandemic

The-present commentary is to discuss the-possible relation between those-factors and SARS-CoV-2 infection

The authors declare that they have no competing interests e. Funding There was no external funding for this study itself. All authors had full access to all of the data in this study and take complete responsibility for the integrity of the data and accuracy of the data analysis.

Ahmed Osama El-Gendy: Concept, planning, and writing